Implement ing Outcomes-based Heal thcare H o w m e a s u r i n g o u t c o m e s l e a d s t o b e t t e r p a t i e n t s ’ h e a l t h a n d s u s t a i n a b l e h e a l t h s y s t e m s1 8 t h O c t o b e r 2 0 1 8 | C r o w n e P l a z a B r u s s e l s - L e P a l a c e

Time Topic Objectives

0900-0930 C o f f e e & W e l c o m e

V A L U E B A S E D H E A L T H C A R E : O B J E C T I V E S & O U T C O M E S

0930-0945IntroductionCatherine Rutten, CEO, pharma.beNathalie Moll, Director General, EFPIA

The road towards sustainable outcomes-based healthcare.

0945-1030The theory of Value Based Health Care – why measure outcomes and cost?Rosna Mortuza, Director of Implementation, ICHOM

An overview of the six building blocks of Value-based Healthcare strategy.

1030-1100How are standard sets made and implemented – use the cataracts standard set? Elizabeth Maclean, Project Leader, ICHOM

Explanation of the academic rigour applied to standard set development and how organisation’s approach measuring them and outcomes utility.

1100-1115 M o r n i n g C o f f e e B r e a k

Time Topic Objectives

1115-1145The approach to building a disease registry – the EUBIROD Project – and the ICHOM Diabetes Standard SetAdjunct Prof Fabrizio Carinci, Università di Bologna

Overview of outcomes measurement in diabetes and reflections upon the barriers and enablers to building a pan-European diabetes registry.

1145-1230 What benefits does outcomes measurement give to a provider? The Martini Klinik approachDr Burkhard Beyer, The Martini Klinik

How does an organisation practically use outcomes data to improve quality of care?

1230-1330 N e t w o r k i n g L u n c h

R E A L - W O R L D E X A M P L E S

1330-1400Case Study: Lung Cancer standard set implementation in BelgiumProfessor Jan van Meerbeeck, University Hospital Antwerp

Practical real-world example of Lung Cancer Standard set implementation.

1400-1445Experiences regarding the implementation of bundled payments.Diane Bell, P A Consulting

How outcomes data can be used to drive reimbursement strategies.

1445-1500 A f t e r n o o n C o f f e e B r e a k

I N T E R A C T I V E D I S C U S S I O N S & O U T C O M E S I N P R A C T I C E

1500-1600 Panel Discussion 1: The role of the EU in outcomes-based healthcare

PannelistsAndrzej Rys, Director for health systems and products, European Commission Nathalie Moll, Director General, EFPIAKaisa Immonen, Director of Policy, EPFStefania Giannico, Secretary General, UEHP

Moderator:Thomas Allvin, Executive Director Strategy and Healthcare Systems, EFPIA

1600-1700 Panel Discussion 2: A national perspective on implementing outcome-based healthcare – practical applications for Belgian stakeholders at a national-level

PannelistsJo De Cock, CEO, National Institute of Health and Disability InsuranceXavier Brenez, CEO, Union of the Mutualites LibresWouter De Ploey, CEO, ZNA Sint-Elisabeth Hospital (Antwerp) Greet Haelterman, MD at Federal Public Service Health, Head of the Quality Unit Food Chain and EnvironmentKarel Van De Sompel, Managing Director Pfizer

Moderator:Stefaan Fiers, Communications & Public Policy Director, pharma.be

1700-1715 Wrap up & closeNathalie Moll, Director General, EFPIA

Summation of days events, and contact information.